Liu, K., Li, L., & Han, G. (2024). CHST12: A potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLiu, Kun, Lu Li, and Guang Han. CHST12: A Potential Prognostic Biomarker Related to the Immunotherapy Response in Pancreatic Adenocarcinoma. Frontiers Media S.A, 2024.
MLA (9th ed.) CitationLiu, Kun, et al. CHST12: A Potential Prognostic Biomarker Related to the Immunotherapy Response in Pancreatic Adenocarcinoma. Frontiers Media S.A, 2024.
Warning: These citations may not always be 100% accurate.